3. METODOLOGÍA
3.1 Tipo de investigación
Hallmarks of BCR signaling are protein phosphorylation and an increase in cellular Ca2+
concentration upon BCR stimulation. BCR cross-‐linking in LCLs, generated from wt EBV infection, induced protein phosphorylation but not Ca2+-‐influx, whereas in ΔLMP2A
LCLs, both processes were activated (Medele, 2010). Why LMP2A blocks Ca2+-‐influx but
not protein phosphorylation is not known. Stable transfection of BJAB cells with a K1 expression plasmid decreased the surface IgM expression suggesting a downregulation of BCR signaling (Lee et al., 2000). Similarly, transient transfection of a K15 expression plasmid into BJAB cells and subsequent BCR cross-‐linking with an α-‐hIgM antibody
reduced the Ca2+-‐influx compared to vector transfected cells (Pietrek et al., 2010). Choi
and colleagues transiently expressed a CD8-‐K15 chimera into BJAB cells, in which the cytoplasmic tail of K15 replaced the cytoplasmic tail of CD8. Cross-‐linking of the BCR with α-‐hIgM antibody slightly decreased tyrosine phosphorylation in Western blot
analysis compared to cells, which express CD8-‐Δ missing the K15 cytoplasmic tail (Choi
Results
Figure 5-23: The KSHV proteins K1 and K15 do not inhibit BCR signaling.
Cross-‐linking with an α-‐hIgG/M antibody can induce BCR signaling and phosphorylation of signaling
molecules, e.g. Syk and PLCγ2, or an influx of calcium into the cytoplasm. A) The increase of Syk and PLCγ2
phosphorylation after BCR stimulation was investigated in established LCLs, which were generated through infection of adenoid B cells with wt EBV, ΔLMP2A EBV, K1 EBV, or K15 EBV strains. An LCL clone,
which was generated from infection with wt EBV and unable to express a BCR (clone A16), was included as negative control. The BCR of the four LCLs was cross-‐linked for 10min with 25µg/ml α-‐hIgG/M
antibody or left untreated. Cells were fixed, permeabilized, and stained with phosphospecific α-‐pSyk-‐
Alexa647 or with α-‐pPLCγ2-‐Alexa647 antibodies. Histograms of flow cytometry analysis are shown.
Numbers next to the graphs display the mean fluorescent intensities for not cross-‐linked (blue) and cross-‐ linked (red) cells. Numbers below the graphs show the fold increases in mean fluorescent intensity of the pSyk-‐ and pPLCγ2-‐signals after BCR stimulation. BCR-‐ wt EBV-‐infected LCLs (clone A16) did not show an
increase in Syk and PLCγ2 phosphorylation after antibody addition, as expected. In LCLs generated from
wt (BCR+), ΔLMP2A EBV, K1 EBV, and K15 EBV strains, BCR cross-‐linking induced a significant increase in
Syk and PLCγ2 phosphorylation indicating that neither LMP2A nor K1 and K15 inhibited phosphorylation
of BCR signaling molecules. B) The same LCLs were loaded with 3µM Indo-‐1 AM, and the ratio of Indo-‐1 in the violet vs. blue channel (y-‐axis) was measured over time (x-‐axis). After one minute of base line measurement the BCR was cross-‐linked with 25µg/ml α-‐hIgG/A/M F(ab)2-‐fragment. An influx of calcium
into the cytoplasm shifts the Indo-‐1 emission to the violet channel increasing the violet/blue ration. BCR-‐
wt EBV-‐infected LCLs (clone A16) did not show an increase in cytoplasmic calcium levels after antibody mediated BCR cross-‐linking, as expected. LCLs generated from wt but not ΔLMP2A EBV strain showed
Results
impaired calcium mobilization after BCR cross-‐link confining that LMP2A blocked BCR’s calcium signaling. In contrast, BCR cross-‐linking induced calcium influx in LCLs generated with K1 EBV and K15 EBV strains suggesting that K1 and K15 proteins did not block BCR-‐mediated calcium signaling.
I infected unsorted cells with wt EBV, ΔLMP2A EBV, K1 EBV, and K15 EBV and
generated LCLs, which expressed high levels of IgG (wt EBV infection) or IgM (ΔLMP2A
EBV, K1 EBV and K15 EBV). I investigated whether K1 and K15 can block BCR signaling by a change in phosphorylated Syk (pSyk) and phosphorylated PLCγ2 (pPLCγ2) levels
and an alteration in Ca2+-‐influx. A wt EBV LCL, unable to express a BCR due to crippled
mutations in the Ig genes (referred as clone A16 in Mancao et al., 2005), was used as negative control for BCR cross-‐linking induced signaling. The BCR was either cross-‐ linked with an α-‐hIgG/M antibody for 10min at 37°C or left untreated. Cells were fixed,
permeabilized, stained with antibodies specific for pSyk or pPLCγ2, and analyzed by
flow cytometry. BCR cross-‐linking increased pSyk and pPLCγ2 levels in all tested cell
lines but the negative control cell line A16 indicating that LMP2A, K1, and K15 did not block BCR induced protein-‐phosphorylation.
The same LCLs were loaded with 3µM Indo-‐1 AM. Indo-‐1 is a fluorescent dye, which changes its emission wavelength from 475nm (blue) to 400nm (violet) upon calcium binding. An increase in cellular Ca2+ can be measured by an increase in the violet/blue
wavelength ratio. The baseline violet/blue ratio of Indo-‐1 loaded LCLs was measured for 1min. Subsequently, the BCR was cross-‐linked with an α-‐hIgG/A/M F(ab’)2 fragment and
the Ca2+-‐influx was measured by the change in the violet/blue ratio for 5min. The Ca2+-‐
influx was impaired in both wt EBV LCLs but not in ΔLMP2A, K1, and K15 EBV LCLs
indicating that LMP2A but not K1 or K15 blocked BCR induced calcium signaling.
Discussion